Interaction networks: Coordinating responses to xenobiotic exposure

Toxicology

Volumn 202, Issue 1-2, 2004, Pages 21-32

  Plant, Nick ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 3A; CYTOCHROME P450 ISOENZYME; CYTOKINE; DRUG METABOLIZING ENZYME; EPIDERMAL GROWTH FACTOR RECEPTOR; GONADOTROPIN; LUTEINIZING HORMONE; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PREGNANE X RECEPTOR; TESTOSTERONE; XENOBIOTIC AGENT;

CELL HYPERPLASIA; CELL INTERACTION; CELL PROLIFERATION; CELL TYPE; CYTOKINE RELEASE; DNA BINDING; ENVIRONMENTAL EXPOSURE; GONADOTROPIN RELEASE; HEPATOMEGALY; HUMAN; HYPERICUM PERFORATUM; KUPFFER CELL; LEYDIG CELL; LIGAND BINDING; LIVER CARCINOGENESIS; LIVER CELL; LIVER CLEARANCE; LIVER MICROSOME METABOLISM; LUTEINIZING HORMONE RELEASE; MACROPHAGE ACTIVATION; MOLECULAR INTERACTION; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; RISK ASSESSMENT; SMOOTH ENDOPLASMIC RETICULUM; TESTOSTERONE METABOLISM; TESTOSTERONE RELEASE; TOXICOKINETICS; TRANSCRIPTION INITIATION;

EID: 4344617972     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2004.06.028     Document Type: Article

References (64)

1. D.R. Bell, R.G. Bars, G.G. Gibson, and C. Elcombe Localization and differential induction of cytochrome P450IVA and Acyl-CoA oxidase in reply to: rat liver Biochem. J. 275 1991 247 252
2. Bleicher, K.H., Bohm, H.J., Muller, K., Alanine, A.I., 2003. Hit and lead generation: beyond high-throughput screening. Nature Reviews-Drug Discovery 2, 369-378.
3. Bojes, H.K., Germolec, D.R., Simeonova, P., Bruccoleri, A., Schoonhoven, R., Luster, M.I., Thurman, R.G., 1997. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. Carcinogenesis 18, 669-674.
4. H.K. Bojes, and R.G. Thurman Peroxisome proliferators activate kupffer cells in vivo Cancer Res. 56 1996 1 4
5. Butte, A., 2002. The Use and analysis of microarray data. Nature Reviews-Drug Discovery 1, 951-960.
6. Cattley, R.C., DeLuca, J., Elcombe, C., Fenner-Crisp, P., Lake, B.G., Marsman, D.S., Pastoor, T.A., Popp, J.A., Robinson, D.E., Schwetz, B., Tugwood, J., Wahli, W., 1998. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Reg. Toxicol. Pharmacol. 27, 47-60.
7. Cho, S., Park, S.G., Lee do, H., Park, B.C., 2004. Protein-protein interaction networks: from interactions to networks. J. Biochem. Mol. Biol. 37, 45-52.
8. Chook, Y.M., Blobel, G., 2001. Karyopherins and nuclear import. Curr. Opp. Struct. Biol. 11, 703-715.
9. Christensen, A.K., Peacock, K.C., 1980. Increase in Leydig cell number in testes of adult rats treated chronically with an excess of human chorionic gonadotropin. Biol. Reprod. 22, 383-391.
10. Coulson, M.D., Gibson, G.G., Plant, N., Hammond, T., Graham, M., 2003. Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for leydig cell carcinogenesis. Tox. Appl. Pharm. 192, 154-163.
11. Crunkhorn, S.E., Plant, K.E., Gibson, G.G., Kramer, K., Lyon, J., Lord, P.G., Plant, N.J., 2004. Gene expression changes in rat liver following exposure to liver growth agents: role of Kupffer cells in xenobiotic-mediated liver growth. Biochem. Pharm. 67, 107-118.
12. Decker, K., 1990. Biologically active products of stimulated macrophages (Kupffer cells). Eur. J. Biochem. 192, 245-261.
13. P. Eacho, T. Lanier, and C. Brodheckner Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883 Carcinogenesis 12 1991 1557 1561
14. C.J. Epstein Cell size nuclear content and the development of polyploidy in the mammalian liver Proc. Natl. Acad. Sci. U.S.A. 57 1967 327
15. Erol, E., Kumar, L.S., Cline, G.W., Shulman, G.I., Kelly, D.P., Binas, B., 2004. Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice. Faseb Journal, 18, 347-349.
16. Fielden, M.R., Matthews, J.B., Fertuck, K.C., Halgren, R.G., Zacharewski, T.R., 2002. In silico approaches to mechanistic and predictive toxicology: an introduction to bioinformatics for toxicologists. Crit. Rev. Toxicol. 32, 67-112.
17. R. Gebhardt Metabolic zonation of the liver: regulation and implications for liver function Pharmaceut. Therapeut. 53 1992 275 354
18. A. Geick, M. Eichelbaum, and O. Burk Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin J. Biol. Chem. 276 2001 14581 14587
19. Geysen, H.M., Schoenen, F., Wagner, D., Wagner, R., 2003. Combinatorial compound libraries for drug discovery: an ongoing challenge. Nature Reviews-Drug Discovery 2, 222-230.
20. Gibbs, R.A., Weinstock, G.M., Metzker, M.L., Muzny, D.M., Sodergren, E.J., Scherer, S., Scott, G., Steffen, D., Worley, K.C., Burch, P.E., Okwuonu, G., Hines, S., Lewis, L., DeRamo, C., Delgado, O., Dugan-Rocha, S., Miner, G., Morgan, M., Hawes, A., Gill, R., Celera, Holt, R.A., Adams, M.D., Amanatides, P.G., Baden-Tillson, H., Barnstead, M., Chin, S., Evans, C.A., Ferriera, S., Fosler, C., Glodek, A., Gu, Z., Jennings, D., Kraft, C.L., Nguyen, T., Pfannkoch, C.M., Sitter, C., Sutton, G.G., Venter, J.C., Woodage, T., Smith, D., Lee, H.M., Gustafson, E., Cahill, P., Kana, A., Doucette-Stamm, L., Weinstock, K., Fechtel, K., Weiss, R.B., Dunn, D.M., Green, E.D., Blakesley, R.W., Bouffard, G.G., De Jong, P.J., Osoegawa, K., Zhu, B., Marra, M., Schein, J., Bosdet, I., Fjell, C., Jones, S., Krzywinski, M., Mathewson, C., Siddiqui, A., Wye, N., McPherson, J., Zhao, S., Fraser, C.M., Shetty, J., Shatsman, S., Geer, K., Chen, Y., Abramzon, S., Nierman, W.C., Havlak, P.H., Chen, R., Durbin, K.J., Egan, A., Ren, Y., Song, X.Z., Li, B., Liu, Y., Qin, X., Cawley, S., Cooney, A.J., D'Souza, L.M., Martin, K., Wu, J.Q., Gonzalez-Garay, M.L., Jackson, A.R., Kalafus, K.J., McLeod, M.P., Milosavljevic, A., Virk, D., Volkov, A., Wheeler, D.A., Zhang, Z., Bailey, J.A., Eichler, E.E., Tuzun, E., Birney, E., Mongin, E., Ureta-Vidal, A., Woodwark, C., Zdobnov, E., Bork, P., Suyama, M., Torrents, D., Alexandersson, M., Trask, B.J., Young, J.M., Huang, H., Wang, H., Xing, H., Daniels, S., Gietzen, D., Schmidt, J., Stevens, K., Vitt, U., Wingrove, J., Camara, F., Mar Alba, M., Abril, J.F., Guigo, R., Smit, A., Dubchak, I., Rubin, E.M., Couronne, O., Poliakov, A., Hubner, N., Ganten, D., Goesele, C., Hummel, O., Kreitler, T., Lee, Y.A., Monti, J., Schulz, H., Zimdahl, H., Himmelbauer, H., Lehrach, H., Jacob, H.J., Bromberg, S., Gullings-Handley, J., Jensen-Seaman, M.I., Kwitek, A.E., Lazar, J., Pasko, D., Tonellato, P.J., Twigger, S., Ponting, C.P., Duarte, J.M., Rice, S., Goodstadt, L., Beatson, S.A., Emes, R.D., Winter, E.E., Webber, C., Brandt, P., Nyakatura, G., Adetobi, M., Chiaromonte, F., Elnitski, L., Eswara, P., Hardison, R.C., Hou, M., Kolbe, D., Makova, K., Miller, W., Nekrutenko, A., Riemer, C., Schwartz, S., Taylor, J., Yang, S., Zhang, Y., Lindpaintner, K., Andrews, T.D., Caccamo, M., Clamp, M., Clarke, L., Curwen, V., Durbin, R., Eyras, E., Searle, S.M., Cooper, G.M., Batzoglou, S., Brudno, M., Sidow, A., Stone, E.A., Payseur, B.A., Bourque, G., Lopez-Otin, C., Puente, X.S., Chakrabarti, K., Chatterji, S., Dewey, C., Pachter, L., Bray, N., Yap, V.B., Caspi, A., Tesler, G., Pevzner, P.A., Haussler, D., Roskin, K.M., Baertsch, R., Clawson, H., Furey, T.S., Hinrichs, A.S., Karolchik, D., Kent, W.J., Rosenbloom, K.R., Trumbower, H., Weirauch, M., Cooper, D.N., Stenson, P.D., Ma, B., Brent, M., Arumugam, M., Shteynberg, D., Copley, R.R., Taylor, M.S., Riethman, H., Mudunuri, U., Peterson, J., Guyer, M., Felsenfeld, A., Old, S., Mockrin, S., Collins, F., 2004. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428, 493-521.
21. Gibson, G., Plant, N., Swales, K., Ayrton, A., El-Sankary, W., 2002. Receptor-dependent transcriptional activation of cytochrome P450 3A genes: induction mechanisms, species differences and inter-individual variation in man. Xenobiotica 32, 165-206.
22. Heydens, W.F., Wilson, A.G., Kier, L.D., Lau, H., Thake, D.C., Martens, M.A., 1999. An evaluation of the carcinogenic potential of the herbicide alachlor to man. Hum. Exp. Toxicol. 18, 363-391.
23. I. Issemann, and S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 649
24. Kamiya, A., Inoue, Y., Gonzalez, F.J., 2003. Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology 37, 1375-1384.
25. S.H. Khan, and S. Sorof Liver fatty acid-binding protein specific mediator of the miogenesis induced by two classes of carcinogenic peroxisome proliferator Proc. Natl. Acad. Sci. U.S.A. 91 1994 848 852
26. Kohler, M., Fiebeler, A., Hartwig, M., Thiel, S., Prehn, S., Kettritz, R., Luft, F.C., Hartmann, E., 2002. Differential expression of classical nuclear transport factors during cellular proliferation and differentiation. Cell. Physiol. Biochem. 12, 335-344.
27. E.S. Lander, L.M. Linton, B. Birren, C. Nusbaum, M.C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. Gage, K. Harris, A. Heaford, J. Howland, L. Kann, J. Lehoczky, R. LeVine, P. McEwan, K. McKernan, J. Meldrim, J.P. Mesirov, C. Miranda, W. Morris, J. Naylor, C. Raymond, M. Rosetti, R. Santos, A. Sheridan, C. Sougnez, N. Stange-Thomann, N. Stojanovic, A. Subramanian, D. Wyman, J. Rogers, J. Sulston, R. Ainscough, S. Beck, D. Bentley, J. Burton, C. Clee, N. Carter, A. Coulson, R. Deadman, P. Deloukas, A. Dunham, I. Dunham, R. Durbin, L. French, D. Grafham, S. Gregory, T. Hubbard, S. Humphray, A. Hunt, M. Jones, C. Lloyd, A. McMurray, L. Matthews, S. Mercer, S. Milne, J.C. Mullikin, A. Mungall, R. Plumb, M. Ross, R. Shownkeen, S. Sims, R.H. Waterston, R.K. Wilson, L.W. Hillier, J.D. McPherson, M.A. Marra, E.R. Mardis, L.A. Fulton, A.T. Chinwalla, K.H. Pepin, W.R. Gish, S.L. Chissoe, M.C. Wendl, K.D. Delehaunty, T.L. Miner, A. Delehaunty, J.B. Kramer, L.L. Cook, R.S. Fulton, D.L. Johnson, P.J. Minx, S.W. Clifton, T. Hawkins, E. Branscomb, P. Predki, P. Richardson, S. Wenning, T. Slezak, N. Doggett, J.F. Cheng, A. Olsen, S. Lucas, C. Elkin, E. Uberbacher, M. Frazier, R.A. Gibbs, D.M. Muzny, S.E. Scherer, J.B. Bouck, E.J. Sodergren, K.C. Worley, C.M. Rives, J.H. Gorrell, M.L. Metzker, S.L. Naylor, R.S. Kucherlapati, D.L. Nelson, G.M. Weinstock, Y. Sakaki, A. Fujiyama, M. Hattori, T. Yada, A. Toyoda, T. Itoh, C. Kawagoe, H. Watanabe, Y. Totoki, T. Taylor, J. Weissenbach, R. Heilig, W. Saurin, F. Artiguenave, P. Brottier, T. Bruls, E. Pelletier, C. Robert, P. Wincker, A. Rosenthal, M. Platzer, G. Nyakatura, S. Taudien, A. Rump, H.M. Yang, J. Yu, J. Wang, G.Y. Huang, J. Gu, L. Hood, L. Rowen, A. Madan, S.Z. Qin, R.W. Davis, N.A. Federspiel, A.P. Abola, M.J. Proctor, R.M. Myers, J. Schmutz, M. Dickson, J. Grimwood, D.R. Cox, M.V. Olson, R. Kaul, N. Shimizu, K. Kawasaki, S. Minoshima, G.A. Evans, M. Athanasiou, R. Schultz, B.A. Roe, F. Chen, H.Q. Pan, J. Ramser, H. Lehrach, R. Reinhardt, W.R. McCombie, M. de la Bastide, N. Dedhia, H. Blocker, K. Hornischer, G. Nordsiek, R. Agarwala, L. Aravind, J.A. Bailey, A. Bateman, S. Batzoglou, E. Birney, P. Bork, D.G. Brown, C.B. Burge, L. Cerutti, H.C. Chen, D. Church, M. Clamp, R.R. Copley, T. Doerks, S.R. Eddy, E.E. Eichler, T.S. Furey, J. Galagan, J.G.R. Gilbert, C. Harmon, Y. Hayashizaki, D. Haussler, H. Hermjakob, K. Hokamp, W.H. Jang, L.S. Johnson, T.A. Jones, S. Kasif, A. Kaspryzk, S. Kennedy, W.J. Kent, P. Kitts, E.V. Koonin, I. Korf, D. Kulp, D. Lancet, T.M. Lowe, A. McLysaght, T. Mikkelsen, J.V. Moran, N. Mulder, V.J. Pollara, C.P. Ponting, G. Schuler, J.R. Schultz, G. Slater, A.F.A. Smit, E. Stupka, J. Szustakowki, D. Thierry-Mieg, J. Thierry-Mieg, L. Wagner, J. Wallis, R. Wheeler, A. Williams, Y.I. Wolf, K.H. Wolfe, S.P. Yang, R.F. Yeh, F. Collins, M.S. Guyer, J. Peterson, A. Felsenfeld, K.A. Wetterstrand, A. Patrinos, and M.J. Morgan Initial sequencing and analysis of the human genome Nature 409 2001 860 921
28. S.S.T. Lee, T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez-Salguero, H. Westphal, and F.J. Gonzalez Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the plietropic effects of peroxisome proliferators Mol. Cell Biol. 15 1995 3012 3022
29. Lehmann, J.M., McKee, D.D., Watson, M.A., Willson, T.M., Moore, J.T., Kliewer, S.A., 1998. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102, 1016-1023.
30. Lidke, D.S., Nagy, P., Heintzmann, R., Arndt-Jovin, D.J., Post, J.N., Grecco, H.E., Jares-Erijman, E.A., Jovin, T.M., 2004. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nature Biotechnolgy 22, 198-203 (Epub 2004 January 4).
31. Maglich, J.M., Stoltz, C.M., Goodwin, B., Hawkins-Brown, D., Moore, J.T., Kliewer, S.A., 2002. Nuclear pregnane × receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharm. 62, 638-646.
32. Markowitz, J.S., Donovan, J.L., DeVane, C.L., Taylor, R.M., Ruan, Y., Wang, J.S., Chavin, K.D., 2003. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. J.A.M.A. 290, 1500-1504.
33. McClain, R.M., 1992. Thyroid gland neoplasia: non-genotoxic mechanisms. Toxicol. Lett. 64-65, 397-408.
34. R. Metivier, G. Penot, M.R. Hubner, G. Reid, H. Brand, M. Kos, and F. Gannon Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter Cell 115 2003 751 763
35. Meyer, U.A., Gut, J., 2002. Genomics and the prediction of xenobiotic toxicity. Toxicol. 181-182, 463-466.
36. L.B. Moore, B. Goodwin, S.A. Jones, G.B. Wisely, C.J. Serabjit-Singh, T.M. Willson, J.L. Collins, and S.A. Kliewer St. John's Wort induces hepatic drug metabolism through activation of the pregnane X receptor Proc. Natl. Acad. Sci. U.S.A. Journal of Cell Physiology 97 2000 7500 7502
37. L.B. Moore, D.J. Parks, S.A. Jones, R.K. Bledsoe, T.G. Consler, J.B. Stimmel, B. Goodwin, C. Liddle, S.G. Blanchard, T.M. Willson, J.L. Collins, and S.A. Kliewer Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands J. Biol. Chem. 275 2000 15122 15127
38. Palmer, C.N.A., Hsu, M.H., Griffin, K.J., Raucy, J.L., Johnson, E.F., 1998. Peroxisome proliferator activated receptor-alpha expression in human liver. Mol. Pharm. 53, 14-22.
39. Pascussi, J.-M., Drocourt, L., Fabre, J.-M., Maurel, P., Vilarem, M.-J., 2000a. Dexamethasone induces pregnane × receptor and retinoid × receptor-a expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane × receptor. Mol. Pharm. 58, 361-372.
40. Pascussi, J.-M., Gerbal-Chaloin, S., Fabre, J.-M., Maurel, P., Vilarem, M.-J., 2000b. Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: Consequences on cytochrome P450 gene regulation. Mol. Pharm. 58, 1441-1450.
41. Penzotti, J.E., Landrum, G.A., Putta, S., 2004. Building predictive ADMET models for early decisions in drug discovery. Curr. Op. Drug. Disc. Dev. 7, 49-61.
42. Peters, J.M., Rusyn, I., Rose, M.L., Gonzalez, F.J., Thurman, R.D., 2000. Peroxisome prolliferator activated receptor alpha is restricted to hepatic parencymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in carcinogenesis. Carcinogenesis 21, 823-826.
43. Plant, N., Horley, N., Savory, R., Elcombe, C., Gray, T., Bell, D., 1998. The peroxisome proliferators are hepatocyte mitogens in chemically-defined media: glucocorticoid-induced PPAR alpha is linked to peroxisome proliferator mitogenesis. Carcinogenesis 19, 925-931.
44. Reddy, J.K., Azarnoff, D.L., Hignite, C.E., 1980. Hypolipidemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283, 397-398.
45. J.K. Reddy, and M.S. Rao Malignant tumours in rats fed nafenopin, a hepatic peroxisome proliferator J. Natl. Cancer Inst. 59 1977 1645 1650
46. Remy, I., Michnick, S.W., 2003. Dynamic visualization of expressed gene networks. J. Cell Physiol. 196, 419-429.
47. R. Roberts, A. Soames, J. Gill, N. James, and E. Wheeldon Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations Carcinogenesis 16 1995 1693
48. Rose, M.L., Rusyn, I., Bojes, H.K., Germolec, D.R., Luster, M.I., Thurman, R.G., 1999. Role of Kupffer cells in peroxisome proliferator induced hepatocyte proliferation. Drug Met. Rev. 31, 87-116.
49. Song, X., Xie, M., Zhang, H., Li, Y., Sachdeva, K., Yan, B., 2004. The pregnane X receptor binds to response elements in a genomic context-dependent manner, and PXR activator rifampicin selectively alters the binding among target genes. Drug Met. Disp. 32, 35-42.
50. Styles, J.A., Kelly, M., Pritchard, N.R., Elcombe, C.R., 1988. A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenopate: involvement of the binucleated hepatocyte. Carcinogenesis 9, 1647-1655.
51. Surapureddi, S., Yu, S., Bu, H., Hashimoto, T., Yeldandi, A.V., Kashireddy, P., Cherkaoui-Malki, M., Qi, C., Zhu, Y.J., Rao, M.S., Reddy, J.K., 2002. Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator. P.N.A.S. 99, 11836-11841.
52. Swales, K.E., Plant, N., Ayrton, A., Hood, S., Gibson, G., 2003. Relative receptor expression is a determinant in xenobiotic-mediated CYP3A induction in rat and human cells. Xenobiotica 33, 703-716.
53. Synold, T.W., Dussault, I., Forman, B.M., 2001. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nature Medicine 7, 584-590.
54. Takeshita, A., Taguchi, M., Koibuchi, N., Ozawa, Y., 2002. Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics. J. Biol. Chem. 277, 32453-32458.
55. Waring, J.F., Ciurlionis, R., Jolly, R.A., Heindel, M., Ulrich, R.G., 2001a. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. 120, 359-368.
56. Waring, J.F., Jolly, R.A., Ciurlionis, R., Lum, P.Y., Praestgaard, J.T., Morfitt, D.C., Buratto, B., Roberts, C., Schadt, E., Ulrich, R.G. (2001b) Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Tox. Appl. Pharm. 175, 28-42.
57. R.H. Waterston, K. Lindblad-Toh, E. Birney, J. Rogers, J.F. Abril, P. Agarwal, R. Agarwala, R. Ainscough, M. Alexandersson, P. An, S.E. Antonarakis, J. Attwood, R. Baertsch, J. Bailey, K. Barlow, S. Beck, E. Berry, B. Birren, T. Bloom, P. Bork, M. Botcherby, N. Bray, M.R. Brent, D.G. Brown, S.D. Brown, C. Bult, J. Burton, J. Butler, R.D. Campbell, P. Carninci, S. Cawley, F. Chiaromonte, A.T. Chinwalla, D.M. Church, M. Clamp, C. Clee, F.S. Collins, L.L. Cook, R.R. Copley, A. Coulson, O. Couronne, J. Cuff, V. Curwen, T. Cutts, M. Daly, R. David, J. Davies, K.D. Delehaunty, J. Deri, E.T. Dermitzakis, C. Dewey, N.J. Dickens, M. Diekhans, S. Dodge, I. Dubchak, D.M. Dunn, S.R. Eddy, L. Elnitski, R.D. Emes, P. Eswara, E. Eyras, A. Felsenfeld, G.A. Fewell, P. Flicek, K. Foley, W.N. Frankel, L.A. Fulton, R.S. Fulton, T.S. Furey, D. Gage, R.A. Gibbs, G. Glusman, S. Gnerre, N. Goldman, L. Goodstadt, D. Grafham, T.A. Graves, E.D. Green, S. Gregory, R. Guigo, M. Guyer, R.C. Hardison, D. Haussler, Y. Hayashizaki, L.W. Hillier, A. Hinrichs, W. Hlavina, T. Holzer, F. Hsu, A. Hua, T. Hubbard, A. Hunt, I. Jackson, D.B. Jaffe, L.S. Johnson, M. Jones, T.A. Jones, A. Joy, M. Kamal, E.K. Karlsson, D. Karolchik, A. Kasprzyk, J. Kawai, E. Keibler, C. Kells, W.J. Kent, A. Kirby, D.L. Kolbe, I. Korf, R.S. Kucherlapati, E.J. Kulbokas, D. Kulp, T. Landers, J.P. Leger, S. Leonard, I. Letunic, R. Levine, J. Li, M. Li, C. Lloyd, S. Lucas, B. Ma, D.R. Maglott, E.R. Mardis, L. Matthews, E. Mauceli, J.H. Mayer, M. McCarthy, W.R. McCombie, S. McLaren, K. McLay, J.D. McPherson, J. Meldrim, B. Meredith, J.P. Mesirov, W. Miller, T.L. Miner, E. Mongin, K.T. Montgomery, M. Morgan, R. Mott, J.C. Mullikin, D.M. Muzny, W.E. Nash, J.O. Nelson, M.N. Nhan, R. Nicol, Z. Ning, C. Nusbaum, M.J. O'Connor, Y. Okazaki, K. Oliver, E.O. Larty, L. Pachter, G. Parra, K.H. Pepin, J. Peterson, P. Pevzner, R. Plumb, C.S. Pohl, A. Poliakov, T.C. Ponce, C.P. Ponting, S. Potter, M. Quail, A. Reymond, B.A. Roe, K.M. Roskin, E.M. Rubin, A.G. Rust, R. Santos, V. Sapojnikov, B. Schultz, J. Schultz, M.S. Schwartz, S. Schwartz, C. Scott, S. Seaman, S. Searle, T. Sharpe, A. Sheridan, R. Shownkeen, S. Sims, J.B. Singer, G. Slater, A. Smit, D.R. Smith, B. Spencer, A. Stabenau, N.S. Strange-Thomann, C. Sugnet, M. Suyama, G. Tesler, J. Thompson, D. Torrents, E. Trevaskis, J. Tromp, C. Ucla, A.U. Vidal, J.P. Vinson, A.C. von Niederhausern, C.M. Wade, M. Wall, R.J. Weber, R.B. Weiss, M.C. Wendl, A.P. West, K. Wetterstrand, R. Wheeler, S. Whelan, J. Wierzbowski, D. Willey, S. Williams, R.K. Wilson, E. Winter, K.C. Worley, D. Wyman, S. Yang, S.P. Yang, E.M. Zdobnov, M.C. Zody, and E.S. Lander Initial sequencing and comparative analysis of the mouse genome Nature 420 2002 520 562
58. Waxman, D.J., 1988. Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression. Biochem. Pharm. 37, 71-84.
59. Webster, J.I., Carlstedt-Duke, J., 2002. Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response. J. Steroid Biochem. Mol. Biol. 82, 277-288.
60. Weglarz, T.C., Sandgren, E.P., 2004. Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure. Carcinogenesis 25, 107-12 (Epub 2003 September 26).
61. A.S. Wierzbicki, D.P. Mikhailidis, R. Wray, M. Schachter, R. Cramb, W.G. Simpson, and C.B. Byrne Statin-fibrate combination therapy for hyperlipidaemia: a review Curr. Med. Res. Opin. 19 2003 155 168
62. Winwood, P., Arthur, M., 1998. Kupffer cells and andothelial cells. In: A., Strain, A., Diehl (Eds.). Liver Growth and Repair. Champan and Hall, London, pp. 482-501.
63. Xie, W., Barwick, J.L., Simmon, C.M., Pierce, A.M., Safe, S., Blumberg, B., Guzelian, P.S., Evans, R.M., 2000. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev. 14, 3014-3023.
64. Zhou, S., Lim, L.Y., Chowbay, B., 2004. Herbal modulation of P-glycoprotein. Drug Met. Rev. 36, 57-104.